These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14702843)

  • 21. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
    Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
    Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of respiratory syncytial virus bronchiolitis in hospitalized infants born at 33-36 weeks of gestational age compared with those born at term: a retrospective cohort study.
    Greenberg D; Dagan R; Shany E; Ben-Shimol S; Givon-Lavi N
    Clin Microbiol Infect; 2020 Feb; 26(2):256.e1-256.e5. PubMed ID: 31181285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort.
    Clark SJ; Beresford MW; Subhedar NV; Shaw NJ
    Arch Dis Child; 2000 Oct; 83(4):313-6. PubMed ID: 10999865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
    Lacaze-Masmonteil T; Rozé JC; Fauroux B;
    Pediatr Pulmonol; 2002 Sep; 34(3):181-8. PubMed ID: 12203846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea.
    Lee JH; Kim CS; Chang YS; Choi JH;
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S104-10. PubMed ID: 26566351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA; Cosgrove JF; MacMahon P
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palivizumab efficacy in preterm infants with gestational age < or = 30 weeks without bronchopulmonary dysplasia.
    Grimaldi M; Gouyon B; Sagot P; Quantin C; Huet F; Gouyon JB;
    Pediatr Pulmonol; 2007 Mar; 42(3):189-92. PubMed ID: 17243184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate.
    Hsu CH; Lin CY; Chi H; Chang JH; Hung HY; Kao HA; Peng CC; Jim WT
    PLoS One; 2014; 9(10):e110166. PubMed ID: 25333346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
    Chung A; Reeves RM; Nair H; Campbell H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S592-S598. PubMed ID: 32794556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates.
    Howidi M; Rajah J; Abushrar Z; Parsons H
    J Trop Pediatr; 2007 Feb; 53(1):22-6. PubMed ID: 17008442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study.
    Fjaerli HO; Farstad T; Bratlid D
    BMC Pediatr; 2004 Dec; 4(1):25. PubMed ID: 15606912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions.
    Cooper AC; Banasiak NC; Allen PJ
    Pediatr Nurs; 2003; 29(6):452-6. PubMed ID: 14743842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study.
    Murray J; Bottle A; Sharland M; Modi N; Aylin P; Majeed A; Saxena S;
    PLoS One; 2014; 9(2):e89186. PubMed ID: 24586581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Potential impact and cost-efficacy of bronchiolitis prophylaxis with palivizumab in preterm infants with a gestational age of less than 33 weeks].
    Lapeña López de Armentia S; Robles García MB; Martínez Badás JP; Castañón Fernández L; Mallo Castaño J; Herrero Mendoza B; Alvaro Iglesias E
    An Pediatr (Barc); 2003 Oct; 59(4):328-33. PubMed ID: 14519303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study.
    Gouyon JB; Rozé JC; Guillermet-Fromentin C; Glorieux I; Adamon L; DI Maio M; Miloradovich T; Anghelescu D; Pinquier D; Escande B; Elleau C
    Epidemiol Infect; 2013 Apr; 141(4):816-26. PubMed ID: 22697130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the North Carolina Medicaid Program.
    Wegner S; Vann JJ; Liu G; Byrns P; Cypra C; Campbell W; Stiles A
    Pediatrics; 2004 Dec; 114(6):1612-9. PubMed ID: 15574623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria.
    Resch B; Sommer C; Nuijten MJ; Seidinger S; Walter E; Schoellbauer V; Mueller WD
    Pediatr Infect Dis J; 2012 Jan; 31(1):e1-8. PubMed ID: 21960187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey.
    Prais D; Danino D; Schonfeld T; Amir J
    Chest; 2005 Oct; 128(4):2765-71. PubMed ID: 16236953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions.
    Weisman L
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S33-7; discussion S37-9. PubMed ID: 12671450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis against respiratory syncytial virus in premature infants.
    Bont L; van Vught AJ; Kimpen JL
    Lancet; 1999 Sep; 354(9183):1003-4. PubMed ID: 10501371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.